Pure Membranous Lupus Nephritis: Description of a Cohort of 150 Patients and Review of the Literature.

Estudio retrospectivo Glomerulonefritis membranosa Lupus eritematoso sistémico Membranous glomerulonephritis Retrospective review Systemic lupus erythematosus

Journal

Reumatologia clinica
ISSN: 2173-5743
Titre abrégé: Reumatol Clin (Engl Ed)
Pays: Spain
ID NLM: 101717526

Informations de publication

Date de publication:
Historique:
received: 01 02 2017
revised: 22 03 2017
accepted: 13 04 2017
pubmed: 23 5 2017
medline: 15 6 2019
entrez: 23 5 2017
Statut: ppublish

Résumé

The course and long-term outcome of pure membranous lupus nephritis (MLN) are little understood. The aims of this study are to evaluate the clinical features, course, outcome and prognostic indicators in pure MLN and to determine the impact of ethnicity and the type of health insurance on the course and prognosis of pure MLN. We conducted a retrospective review of medical records of 150 patients with pure MLN from Spain and the USA. Mean age was 34.2±12.5 and 80% were women. Sixty-eight percent of patients had nephrotic syndrome at diagnosis. The average serum creatinine was 0.98±0.78mg/dl. Six percent of patients died and 5.3% developed end-stage renal disease (ESRD). ESRD was predicted by male sex, hypertension, dyslipidemia, high basal 24h-proteinuria, high basal serum creatinine and a low basal creatinine clearance. Age, cardiac insufficiency, peripheral artheriopathy, hemodialysis and not having received mycophenolate mofetil or antimalarials for MLN predicted death. Pure MLN frequently presents with nephrotic syndrome, high proteinuria and normal serum creatinine. Its prognosis is favourable in maintaining renal function although proteinuria usually persists over time. Baseline cardiovascular disease and not having a health insurance are related with poor prognosis.

Identifiants

pubmed: 28528869
pii: S1699-258X(17)30096-7
doi: 10.1016/j.reuma.2017.04.005
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng spa

Sous-ensembles de citation

IM

Pagination

34-42

Informations de copyright

Copyright © 2017 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.

Auteurs

Lucía Silva-Fernández (L)

Servicio de Reumatología, Complexo Hospitalario Universitario de Ferrol, Ferrol, A Coruña, Spain. Electronic address: luciasilva@ser.es.

Teresa Otón (T)

Servicio de Reumatología, Instituto de Salud Musculoesquelética, Madrid, Spain.

Anca Askanase (A)

Rheumatology Department, Hospital for Joint Diseases, New York, USA.

Patricia Carreira (P)

Servicio de Reumatología, Hospital Universitario 12 de Octubre, Madrid, Spain.

Francisco Javier López-Longo (FJ)

Servicio de Reumatología, Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Alejandro Olivé (A)

Servicio de Reumatología, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain.

Íñigo Rúa-Figueroa (Í)

Servicio de Reumatología, Hospital Universitario Doctor Negrín, Las Palmas de Gran Canaria, Spain.

Javier Narváez (J)

Servicio de Reumatología, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.

Esther Ruiz-Lucea (E)

Servicio de Reumatología, Hospital de Basurto, Bilbao, Spain.

Mariano Andrés (M)

Servicio de Reumatología, Hospital General Universitario de Alicante, Alicante, Spain.

Enrique Calvo (E)

Servicio de Reumatología, Hospital Universitario Infanta Sofía, San Sebastián de los Reyes, Madrid, Spain.

Francisco Toyos (F)

Servicio de Reumatología, Hospital Universitario Virgen Macarena, Sevilla, Spain.

Juan José Alegre-Sancho (JJ)

Servicio de Reumatología, Hospital Universitario Doctor Peset, Valencia, Spain.

Eva Tomero (E)

Servicio de Reumatología, Hospital Universitario de La Princesa, Madrid, Spain.

Carlos Montilla (C)

Servicio de Reumatología, Hospital Universitario de Salamanca, Salamanca, Spain.

Antonio Zea (A)

Servicio de Reumatología, Hospital Universitario Ramón y Cajal, Madrid, Spain.

Esther Uriarte (E)

Servicio de Reumatología, Hospital Universitario Donostia, San Sebastián, Spain.

Jaime Calvo-Alén (J)

Servicio de Reumatología, Hospital Sierrallana, Torrelavega, Cantabria, Spain.

Carlos Marras (C)

Servicio de Reumatología, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain.

Víctor M Martínez-Taboada (VM)

Servicio de Reumatología, Hospital Universitario Marqués de Valdecilla, Santander, Spain.

María Ángeles Belmonte-López (MÁ)

Unidad de Investigación del Servicio de Reumatología, Hospital Universitario Carlos Haya, Málaga, Spain.

José Rosas (J)

Servicio de Reumatología, Hospital de la Marina Baixa, Villajoyosa, Alicante, Spain.

Enrique Raya (E)

Servicio de Reumatología, Hospital Universitario San Cecilio, Granada, Spain.

Gema Bonilla (G)

Servicio de Reumatología, Hospital Universitario La Paz, Madrid, Spain.

Mercedes Freire (M)

Servicio de Reumatología, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain.

José María Pego-Reigosa (JM)

Servicio de Reumatología, Complexo Hospitalario Universitario de Vigo, Vigo, Pontevedra, Spain.

Isabel Millán (I)

Departamento de Bioestadística, Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Madrid, Spain.

Adwoa Hughes-Morley (A)

Institute of Population Health, The University of Manchester, Manchester, United Kingdom.

José Luis Andreu (JL)

Servicio de Reumatología, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH